
Paclitaxel Liposomal Suppliers & Bulk Manufacturers
Available Forms: Injection (IV administration)
Available Strengths: 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL
Reference Brands: Taxol®, Abraxane® (US & EU)
Category: Oncology Cancer Care
Paclitaxel liposomal is available in Injection (IV administration) and strengths such as 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Paclitaxel liposomal is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Paclitaxel liposomal can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Paclitaxel, marketed as Taxol® and Abraxane®, is a critical chemotherapy agent used to treat various cancers, including ovarian, breast, and lung cancer. Available in IV injection forms, with strengths like 30 mg/5 mL, 100 mg/16.7 mL, and 300 mg/50 mL, Paclitaxel works by stabilizing microtubules to prevent cell division. Widely sourced by B2B pharmaceutical suppliers globally, Paclitaxel ensures GMP-compliant manufacturing and reliable supply to hospitals and oncology centers in the US and EU. With competitive pricing, it is a vital component in cancer treatment regimens, providing effective therapy for aggressive cancers.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Daratumumab
Strength:
100 mg/5 mL, 400 mg/20 mL
Form: Injection
Reference Brands: Darzalex (USA/EU)
View DetailsPembrolizumab Inj
Strength:
25 mg/mL
Form: Injection
Reference Brands: Keytruda (USA/EU)
View DetailsLeuprolide
Strength:
3.75 mg, 7.5 mg
Form: Injection
Reference Brands: Lupron (USA), Eligard (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers